News and Trends 11 Nov 2022
Prurigo nodularis treatment recommended for EU approval
…often co-morbid diseases. These diseases include approved indications for Dupixent, such as atopic dermatitis, asthma and chronic rhinosinusitis with nasal polyposis (CRSwNP), as well as investigational diseases prurigo nodularis and…